KAMPANYE EDUKATIF MENYAYANGI KUCING UNTUK ANAK USIA DINI. Jelita Syahla Sabrina: 186010050

Kucing merupakan salah satu hewan peliharaan yang sedang meningkat untuk diminati sebagai hewan peliharaan, peningkatan tersebut terjadi khususnya saat pandemi COVID-19 berlangsung. Memelihara hewan peliharaan khususnya kucing sudah menjadi lifestyle dan fenomena menarik selama pandemi COVID-19 tersebut berlangsung. Kucing tak hanya diminati dan digemari oleh kalangan usia menengah ke atas saja namun juga anak kecil, dengan begitu banyak anak kecil yang menaruh perhatian kepada kucing. Kucing dengan manusia khususnya dengan anak kecil memiliki ikatan yang menguntungkan, salah satunya adalah kucing dapat mengurasi rasa kecemasan juga kesejahteraan berupa mental dan fisik. Namun, dibalik ketertarikan tersebut, masih banyak anak kecil yang lalai baik dalam memelihara juga memperlakukan kucing dengan baik, seperti menjahilinya walau dengan atas dasar bercanda dan gemas. Dengan begitu, dengan memanfaatkan ketertarikan tersebut, dibutuhkan edukasi untuk anak usia dini dengan merancang media berupa kegiatan yang menyenangkan dengan cerita kehidupan sehari-hari sehingga terdapat pembelajaran yang diambil dan dapat diaplikasikan ke kehidupan sehari-harinya dan memperlakukan hewan khususnya kucing dengan baik layaknya teman sehingga baik kucing dan anak tidak ada yang dirugikan. Untuk mempermudah proses perancangan, digunakan metode deskriptif kualitatif yaitu dengan melakukan kuesioner, wawancara, dan studi literatur. Perancangan pembelajaran untuk menyayangi kucing untuk anak usia dini digunakan metode storytelling yaitu buku interaktif dengan beberapa kegiatan seru di dalamnya seperti pop up, lift the flap, mencari gambar tersembunyi, dan DIY puppet sehingga membaca menjadi kegiatan menyenangkan. dengan media pendukung podcast atau audio book diharapkan anak usia dini dapat menumbuhkan rasa kasih sayang kepada kucing dan memperlakukannya dengan baik layaknya teman sendiri. Kata kunci: Kucing, anak usia dini, buku interaktif, hewan peliharaa

On the Munn-Silbey approach to polaron transport with off-diagonal coupling

Improved results using a method similar to the Munn-Silbey approach have been obtained on the temperature dependence of transport properties of an extended Holstein model incorporating simultaneous diagonal and off-diagonal exciton-phonon coupling. The Hamiltonian is partially diagonalized by a canonical transformation, and optimal transformation coefficients are determined in a self-consistent manner. Calculated transport properties exhibit substantial corrections on those obtained previously by Munn and Silbey for a wide range of temperatures thanks to a numerically exact evaluation and an added momentum-dependence of the transformation matrix. Results on the diffusion coefficient in the moderate and weak coupling regime show distinct band-like and hopping-like transport features as a function of temperature.Comment: 12 pages, 6 figures, accpeted in Journal of Physical Chemistry B: Shaul Mukamel Festschrift (2011

Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma

Drug-induced multidrug resistance (MDR) has been linked to overexpression of drug transporting proteins in head and neck squamous cell carcinoma (HNSCC) in vitro. The aim of this work was to reassess these findings in a murine xenograft model. NOD-SCID mice xenotransplanted with 106 HNO97 cells were treated for four consecutive weeks with weekly paclitaxel, biweekly cisplatin (both intraperitoneal), or 5-fluorouracil (5-FU, administered by osmotic pump). Tumor volume and body weight were weekly documented. Expression of drug transporters and Ki-67 marker were examined using quantitative real-time polymerase chain reaction and/or immunohistochemistry. Both paclitaxel and cisplatin significantly reduced tumor volumes after 2–3 weeks. 5-FU-treated animals had significantly lower body weights after 2 or 4 weeks of chemotherapy. None of the drugs affected expression of drug transporters at the mRNA level. However, P-glycoprotein (Pgp) protein expression was increased by paclitaxel (P < 0.01). Ki-67 expression did not change during treatment irrespective of the drug applied. Paclitaxel and cisplatin are effectively tumor volume reducing drugs in a murine xenograft model of HNSCC. Paclitaxel enhanced Pgp expression at the protein level, but not at the mRNA level suggesting transcriptional induction to be of minor relevance. In contrast, posttranscriptional mechanisms or Darwinian selection of intrinsically drug transporter overexpressing MDR cells might lead to iatrogenic chemotherapy resistance in HNSCC.Fil: Theile, Dirk. Universität Heidelberg; AlemaniaFil: Gal, Zoltan. Universität Heidelberg; AlemaniaFil: Warta, Rolf. Universität Heidelberg; AlemaniaFil: Rigalli, Juan Pablo. Universität Heidelberg; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Lahrmann, Bernd. Universität Heidelberg; AlemaniaFil: Grabe, Niels. Universität Heidelberg; AlemaniaFil: Herold Mende, Christel. Universität Heidelberg; AlemaniaFil: Dyckhoff, Gerhard. Universität Heidelberg; AlemaniaFil: Weiss, Johanna. Universität Heidelberg; Alemani

Withdrawing biologics in non-systemic JIA:what matters to pediatric rheumatologists?

Abstract Objective Approximately one third of children with JIA receive biologic therapy, but evidence on biologic therapy withdrawal is lacking. This study aims to increase our understanding of whether and when pediatric rheumatologists postpone a decision to withdraw biologic therapy in children with clinically inactive non-systemic JIA. Methods A survey containing questions about background characteristics, treatment patterns, minimum treatment time with biologic therapy, and 16 different patient vignettes, was distributed among 83 pediatric rheumatologists in Canada and the Netherlands. For each vignette, respondents were asked whether they would withdraw biologic therapy at their minimum treatment time, and if not, how long they would continue biologic therapy. Statistical analysis included descriptive statistics, logistic and interval regression analysis. Results Thirty-three pediatric rheumatologists completed the survey (40% response rate). Pediatric rheumatologists are most likely to postpone the decision to withdraw biologic therapy when the child and/or parents express a preference for continuation (OR 6.3; p < 0.001), in case of a flare in the current treatment period (OR 3.9; p = 0.001), and in case of uveitis in the current treatment period (OR 3.9; p < 0.001). On average, biologic therapy withdrawal is initiated 6.7 months later when the child or parent prefer to continue treatment. Conclusion Patient’s and parents' preferences were the strongest driver of a decision to postpone biologic therapy withdrawal in children with clinically inactive non-systemic JIA and prolongs treatment duration. These findings highlight the potential benefit of a tool to support pediatric rheumatologists, patients and parents in decision making, and can help inform its design

Results from the Second International Module Inter-comparison

Most photovoltaic (PV) manufacturers trace their peakwatt rating through calibrations/measurements performed at recognized terrestrial calibration facilities. This paper summarizes the results of one such measurement performed by many different calibration facilities. The participants were selected from around the world based on their designation as a national PV calibration facility, prior participation in inter-comparisons, or as an ISO 17025-accredited PV module qualification or certification facility. Each facility was sent the same devices and was requested to treat them as a regular measurement. The modules were selected from newer thin-film manufacturers - ones that might stretch or exceed the current scope of capabilities of the different participants. A concentrator module was even included as part of the set. Short-circuit current (Isc), open-circuit voltage (Voc), fill factor (FF), and peak power (Pmax) results are reported

Community Monitoring of Carbon Stocks for REDD+: Does Accuracy and Cost Change over Time?

Reducing emissions from deforestation and forest degradation in developing countries, and the role of conservation, sustainable management of forests, and enhancement of forest carbon stocks in developing countries (REDD+) is a potentially powerful international policy mechanism that many tropical countries are working towards implementing. Thus far, limited practical consideration has been paid to local rights to forests and forest resources in REDD+ readiness programs, beyond noting the importance of these issues. Previous studies have shown that community members can reliably and cost-effectively monitor forest biomass. At the same time, this can improve local ownership and forge important links between monitoring activities and local decision-making. Existing studies have, however, been static assessments of biomass at one point in time. REDD+ programs will require repeated surveys of biomass over extended time frames. Here, we examine trends in accuracy and costs of local forest monitoring over time. We analyse repeated measurements by community members and professional foresters of 289 plots over two years in four countries in Southeast Asia. This shows, for the first time, that with repeated measurements community members’ biomass measurements become increasingly accurate and costs decline. These findings provide additional support to available evidence that community members can play a strong role in monitoring forest biomass in the local implementation of REDD+

The regulatory mechanisms of NG2/CSPG4 expression

Neuron-glial antigen 2 (NG2), also known as chondroitin sulphate proteoglycan 4 (CSPG4), is a surface type I transmembrane core proteoglycan that is crucially involved in cell survival, migration and angiogenesis. NG2 is frequently used as a marker for the identification and characterization of certain cell types, but little is known about the mechanisms regulating its expression. In this review, we provide evidence that the regulation of NG2 expression underlies inflammation and hypoxia and is mediated by methyltransferases, transcription factors, including Sp1, paired box (Pax) 3 and Egr-1, and the microRNA miR129-2. These regulatory factors crucially determine NG2-mediated cellular processes such as glial scar formation in the central nervous system (CNS) or tumor growth and metastasis. Therefore, they are potential targets for the establishment of novel NG2-based therapeutic strategies in the treatment of CNS injuries, cancer and other conditions of these types

A European proficiency test on thin film tandem photovoltaic devices

A round robin proficiency test RR PT on thin film multi junction MJ photovoltaic PV cells was run between 13 laboratories within the European project CHEETAH. Five encapsulated PV cells were circulated to participants for being tested at Standard Test Conditions STC . Three cells were a Si amp; 956;c Si tandem PV devices, each of which had a different short circuit current ratio between the top junction and the bottom one; the remaining two cells were single junction PV devices made with material representative of the individual junctions in the MJ cells. The RR PT s main purpose was to assess the capability of the participating laboratories, in terms of employed facilities and procedures, to test MJ PV devices. Therefore, participant